Cargando…
Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl(4)-induced liver fibrosis
BACKGROUND: Rifaximin is a poorly absorbed broad-spectrum antibiotic used for hepatic encephalopathy. Although increased Lactobacillaceae and decreased Bacteroidetes abundance are characteristic of hepatic encephalopathy, rifaximin does not dramatically alter the stool microbiota. As the antimicrobi...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029291/ https://www.ncbi.nlm.nih.gov/pubmed/36945059 http://dx.doi.org/10.1186/s13099-023-00541-4 |